Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Th2-polarized immune response and regulatory T cell (Treg) pathways constitute a fundamental immunological axis that determines the body's reaction to allergens. A Th2-polarized state is characterized by the activation of the transcription factor GATA3 and the secretion of cytokines such as IL-4, IL-5, and IL-13, which drive IgE-mediated allergic inflammation. Conversely, Treg pathways, characterized by the transcription factor FOXP3, serve to maintain immune homeostasis and induce tolerance by suppressing excessive Th2 activity (Garcés-Rimón et al., 2016, PubMed: 27501844). Enzymatically hydrolyzed egg white (EHEW) is a functional food ingredient containing bioactive peptides that act as immunomodulators to shift this balance toward tolerance, making it a therapeutic candidate for managing egg allergies (Lozano-Ojalvo et al., 2016, PubMed: 26857538). Although the provided name refers to a complex biological process and an intervention rather than a single molecular target, the individual components of these pathways, such as the transcription factors GATA3 and FOXP3, are the actual molecular targets for therapeutic intervention. Understanding this pathway is crucial for developing strategies to treat atopic diseases and food hypersensitivity.
Enzymatically hydrolyzed egg white (EHEW) modulates the immune system by providing bioactive peptides that promote the differentiation of FOXP3+ regulatory T cells (Tregs) and suppress the GATA3-mediated Th2 response, thereby reducing the production of pro-allergic cytokines like IL-4 and IL-13 and increasing the production of regulatory cytokines like IL-10 (Garcés-Rimón et al., 2016, PubMed: 27501844).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Th2-polarized immune response and regulatory T cell pathways.